Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $12.29 million. The enterprise value is $3.52 million.
| Market Cap | 12.29M |
| Enterprise Value | 3.52M |
Important Dates
The last earnings date was Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QNRX has 2.01 million shares outstanding. The number of shares has increased by 485.24% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.01M |
| Shares Change (YoY) | +485.24% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 6.24% |
| Owned by Institutions (%) | 40.18% |
| Float | 1.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.13 |
| P/TBV Ratio | 3.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.76 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -575.73% and return on invested capital (ROIC) is -214.99%.
| Return on Equity (ROE) | -575.73% |
| Return on Assets (ROA) | -114.60% |
| Return on Invested Capital (ROIC) | -214.99% |
| Return on Capital Employed (ROCE) | -357.43% |
| Weighted Average Cost of Capital (WACC) | 11.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.11M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.07% in the last 52 weeks. The beta is 1.66, so QNRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -17.07% |
| 50-Day Moving Average | 4.67 |
| 200-Day Moving Average | 8.12 |
| Relative Strength Index (RSI) | 64.82 |
| Average Volume (20 Days) | 1,563,603 |
Short Selling Information
The latest short interest is 111,299, so 5.56% of the outstanding shares have been sold short.
| Short Interest | 111,299 |
| Short Previous Month | 115,830 |
| Short % of Shares Out | 5.56% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.15M |
| Pretax Income | -18.67M |
| Net Income | -18.67M |
| EBITDA | -19.05M |
| EBIT | -19.15M |
| Earnings Per Share (EPS) | -$8.52 |
Balance Sheet
The company has $10.80 million in cash and $2.02 million in debt, with a net cash position of $8.78 million or $4.37 per share.
| Cash & Cash Equivalents | 10.80M |
| Total Debt | 2.02M |
| Net Cash | 8.78M |
| Net Cash Per Share | $4.37 |
| Equity (Book Value) | 3.93M |
| Book Value Per Share | 1.96 |
| Working Capital | 5.02M |
Cash Flow
| Operating Cash Flow | -15.27M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 100,000 |
| Net Borrowing | -600,000 |
| Free Cash Flow | -15.27M |
| FCF Per Share | -$7.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -485.24% |
| Shareholder Yield | -485.24% |
| Earnings Yield | -151.86% |
| FCF Yield | -124.26% |
Analyst Forecast
The average price target for QNRX is $21.40, which is 249.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.40 |
| Price Target Difference | 249.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:35.
| Last Split Date | Apr 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |